Avanceon Limited (PSX: AVN)
Pakistan
· Delayed Price · Currency is PKR
56.28
0.00 (0.00%)
At close: Nov 14, 2024
Avanceon Income Statement
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 18,756 | 17,767 | 9,538 | 7,118 | 6,445 | 4,896 | Upgrade
|
Revenue Growth (YoY) | 43.47% | 86.27% | 34.01% | 10.45% | 31.63% | 40.66% | Upgrade
|
Cost of Revenue | 12,980 | 12,161 | 7,032 | 4,840 | 4,603 | 3,412 | Upgrade
|
Gross Profit | 5,777 | 5,606 | 2,507 | 2,278 | 1,842 | 1,484 | Upgrade
|
Selling, General & Admin | 1,481 | 5,961 | 1,818 | 931.12 | 667.48 | 605.97 | Upgrade
|
Other Operating Expenses | 138.4 | -4,322 | -31.65 | -26.9 | -40.49 | -36.3 | Upgrade
|
Operating Expenses | 1,620 | 1,638 | 1,786 | 906.6 | 644.04 | 670.65 | Upgrade
|
Operating Income | 4,157 | 3,968 | 720.93 | 1,371 | 1,198 | 813.3 | Upgrade
|
Interest Expense | -319.72 | -238.22 | -66.99 | -62.5 | -103.4 | -78.43 | Upgrade
|
Interest & Investment Income | 13.98 | 13.7 | 6.89 | 4.46 | 7.31 | 13.04 | Upgrade
|
Earnings From Equity Investments | 110.37 | 110.37 | - | - | - | - | Upgrade
|
Currency Exchange Gain (Loss) | -843.41 | 28.76 | 562.17 | 494.52 | 106.17 | 255.98 | Upgrade
|
Other Non Operating Income (Expenses) | -170.41 | -170.41 | -156.06 | -62.12 | -28.94 | -44.23 | Upgrade
|
EBT Excluding Unusual Items | 2,948 | 3,712 | 1,067 | 1,745 | 1,179 | 959.67 | Upgrade
|
Gain (Loss) on Sale of Investments | -0.02 | -0.02 | - | 0.28 | 1.51 | 0.19 | Upgrade
|
Gain (Loss) on Sale of Assets | 15.9 | 8.57 | 14.8 | 12.96 | 3.21 | 2.69 | Upgrade
|
Pretax Income | 2,964 | 3,720 | 1,082 | 1,759 | 1,183 | 962.94 | Upgrade
|
Income Tax Expense | 1,095 | 1,110 | 154.67 | 158.61 | 138.4 | 50.76 | Upgrade
|
Earnings From Continuing Operations | 1,869 | 2,611 | 927.08 | 1,600 | 1,045 | 912.18 | Upgrade
|
Minority Interest in Earnings | -31 | -95.35 | -81.01 | -23.06 | - | - | Upgrade
|
Net Income | 1,838 | 2,515 | 846.06 | 1,577 | 1,045 | 912.18 | Upgrade
|
Net Income to Common | 1,838 | 2,515 | 846.06 | 1,577 | 1,045 | 912.18 | Upgrade
|
Net Income Growth | 66.02% | 197.30% | -46.35% | 50.91% | 14.56% | 31.88% | Upgrade
|
Shares Outstanding (Basic) | 413 | 413 | 413 | 412 | 402 | 402 | Upgrade
|
Shares Outstanding (Diluted) | 418 | 420 | 420 | 418 | 411 | 410 | Upgrade
|
Shares Change (YoY) | -3.02% | - | 0.35% | 1.72% | 0.29% | 0.19% | Upgrade
|
EPS (Basic) | 4.44 | 6.09 | 2.05 | 3.83 | 2.60 | 2.27 | Upgrade
|
EPS (Diluted) | 4.40 | 5.99 | 2.02 | 3.77 | 2.54 | 2.22 | Upgrade
|
EPS Growth | 70.94% | 196.84% | -46.48% | 48.45% | 14.22% | 31.50% | Upgrade
|
Free Cash Flow | 656.95 | -829.35 | 72.3 | -109.68 | 676.49 | -119.38 | Upgrade
|
Free Cash Flow Per Share | 1.57 | -1.98 | 0.17 | -0.26 | 1.65 | -0.29 | Upgrade
|
Dividend Per Share | 1.818 | 1.818 | - | 0.632 | 0.527 | - | Upgrade
|
Dividend Growth | - | - | - | 20.00% | - | - | Upgrade
|
Gross Margin | 30.80% | 31.55% | 26.28% | 32.00% | 28.57% | 30.31% | Upgrade
|
Operating Margin | 22.16% | 22.33% | 7.56% | 19.26% | 18.58% | 16.61% | Upgrade
|
Profit Margin | 9.80% | 14.16% | 8.87% | 22.16% | 16.21% | 18.63% | Upgrade
|
Free Cash Flow Margin | 3.50% | -4.67% | 0.76% | -1.54% | 10.50% | -2.44% | Upgrade
|
EBITDA | 4,221 | 4,003 | 772.71 | 1,393 | 1,215 | 829.11 | Upgrade
|
EBITDA Margin | 22.50% | 22.53% | 8.10% | 19.57% | 18.85% | 16.93% | Upgrade
|
D&A For EBITDA | 64.04 | 35.69 | 51.78 | 21.91 | 17.22 | 15.81 | Upgrade
|
EBIT | 4,157 | 3,968 | 720.93 | 1,371 | 1,198 | 813.3 | Upgrade
|
EBIT Margin | 22.16% | 22.33% | 7.56% | 19.26% | 18.58% | 16.61% | Upgrade
|
Effective Tax Rate | 36.95% | 29.83% | 14.30% | 9.02% | 11.69% | 5.27% | Upgrade
|
Advertising Expenses | - | 8.53 | 2.58 | 5.88 | 3.25 | 3.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.